Back to Authors

Pinon, Delia I.

A5037721846 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 14

Differential Spatial Approximation between Secretin and Its Receptor Residues in Active and Inactive Conformations Demonstrated by Photoaffinity Labeling

Molecular Endocrinology | March 3, 2006 | Volume: 20 | Issue: 7 | Pages: 1688-1698

10.1210/me.2006-0009 | PMID 16513792

AbstractUnderstanding of the conformational changes in G protein-coupled receptors associated with activation and inactivation is of great interest. We previously used photoaffinity labeling to elucidate spatial approximations between photolabile residues situated throughout the pharmacophore of secretin agonist probes and this receptor. The aim of the current work was to develop analogous photolabile secretin antagonist probes and to explore their spatial approximations. The most potent secretin antagonist reported is a pseudopeptide ([ψ4, 5]secretin) in which the peptide bond between residues 4 and 5 was replaced by a ψ(CH2-NH) peptide bond isostere. We have developed a series of [ψ4, 5]secretin analogs incorporating photolabile benzoyl phenylalanine residues in positions 6, 22, and 26. Each bound to the secretin receptor saturably and specifically, with affinity similar to their parental peptide. At concentrations with no measurable agonist activity, each probe covalently labeled the secretin receptor. Peptide mapping using proteolytic cleavage, immunoprecipitation, and radiochemical sequencing identified that each of these three probes labeled the amino terminus of the secretin receptor. Whereas the position 22 probe labeled the same residue as its analogous agonist probe and the position 6 probe labeled a residue within two residues of that labeled by its analogous agonist probe, the position 26 probe labeled a site 16 residues away from that labeled by its analogous agonist probe. Thus, whereas structurally related agonist and antagonist probes dock in the same general region of this receptor, conformational differences in active and inactive states result in substantial differences in spatial approximation at the carboxyl-terminal end of secretin analogs.
Differential Docking of High-Affinity Peptide Ligands to Type A and B Cholecystokinin Receptors Demonstrated by Photoaffinity Labeling

Biochemistry | April 26, 2005 | Volume: 44 | Issue: 17 | Pages: 6693-6700

10.1021/bi050130q | PMID 15850403

Insights into the Structure and Molecular Basis of Ligand Docking to the G Protein-Coupled Secretin Receptor Using Charge-Modified Amino-Terminal Agonist Probes

Molecular Endocrinology | February 25, 2005 | Volume: 19 | Issue: 7 | Pages: 1821-1836

10.1210/me.2004-0421 | PMID 15731172

A Peptide Agonist Acts by Occupation of a Monomeric G Protein-Coupled Receptor:  Dual Sites of Covalent Attachment to Domains Near TM1 and TM7 of the Same Molecule Make Biologically Significant Domain-Swapped Dimerization Unlikely

Journal of Medicinal Chemistry | July 26, 2002 | Volume: 42 | Issue: 12 | Pages: 2105-2111

10.1021/jm980732q | PMID 10377216